Kojin
is a Massachusetts-based biotechnology company that researches and develops cell-state biological therapeutics for the treatment of cancer, ischemia and fibrosis... Read moreKojin
is a Massachusetts-based biotechnology company that researches and develops cell-state biological therapeutics for the treatment of cancer, ischemia and fibrosis... Read more
2019
PrivateIndependent Company
News
Feb 14, 2025
Endpoints News
Kojin: Kojin Therapeutics shuts down, citing lack of investor interest and complex science
Jan 03, 2024
The Business Journals
Kojin: Harvey Berger leaves biotech 'sidelines' for new CEO gig
Oct 16, 2021
The Business Journals
Kojin: With CEO hire, this biotech boasts an all-women C-suite
Oct 14, 2021
Business Wire
Press Release: Kojin : Kojin Therapeutics Announces Luba Greenwood as Chief Executive Officer
Jun 14, 2021
Global Legal Chronicle
Kojin: Kojin Therapeutics' $60 Million Series A Financing
Jun 09, 2021
BioSpace
Kojin: Kojin Therapeutics Debuts to Solve Difficult Diseases Through Cell Behavior
Jun 09, 2021
FierceBiotech
Kojin: Kojin bags $60M to exploit weakness of drug-resistant cancers
Jun 09, 2021
BioSpace
Kojin: Kojin Therapeutics Launches with $60 Million Series A to Develop New Category of Drugs Based on Cell State Biology
Kojin Competitors
1
2
3
4
5
6
7
8
9
10